View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

XPO Reports Fourth Quarter 2025 Results

XPO Reports Fourth Quarter 2025 Results GREENWICH, Conn., Feb. 05, 2026 (GLOBE NEWSWIRE) -- (NYSE: ) today announced its financial results for the fourth quarter 2025. The company reported diluted earnings per share of $0.50, compared with $0.63 for the same period in 2024, and adjusted diluted earnings per share of $0.88, compared with $0.89 for the same period in 2024. Fourth Quarter 2025 Summary Results                   Three Months Ended December 31,  Revenue Operating Income (Loss) (1)(in millions)  2025  2024 Change %  2025  2024 Change %North American Less-Than-Truckload Segment ...

Martial Descoutures
  • Martial Descoutures
Martial Descoutures
  • Martial Descoutures
 PRESS RELEASE

Two XPO Drivers Selected for America’s Road Team

Two XPO Drivers Selected for America’s Road Team Greenwich, Conn., Jan. 29, 2026 (GLOBE NEWSWIRE) --  (NYSE: XPO), a leading provider of freight transportation in North America, announced today that two of its drivers have been selected to serve as Captains for the 2026-2027 America’s Road Team.Established in 1986 by the American Trucking Associations, America’s Road Team is an elite group of professional truck drivers who serve as ambassadors for the trucking industry. Through public outreach, educational events and meetings with policymakers nationwide, they promote safe driving and the...

 PRESS RELEASE

XPO Named a World’s Most Admired Company by Fortune

XPO Named a World’s Most Admired Company by Fortune GREENWICH, Conn., Jan. 21, 2026 (GLOBE NEWSWIRE) --  (NYSE: XPO), a leading provider of freight transportation in North America, announced today that it has been named to Fortune’s list of the World’s Most Admired Companies for 2026. XPO is the only pure-play North American LTL transportation provider on the list this year.  Mario Harik, chairman and chief executive officer of XPO, said, “This recognition reflects the world-class team we have at XPO. Our success is a direct result of the exceptional service they provide our customers, a...

 PRESS RELEASE

XPO Schedules Fourth Quarter 2025 Earnings Conference Call for Thursda...

XPO Schedules Fourth Quarter 2025 Earnings Conference Call for Thursday, February 5, 2026 GREENWICH, Conn., Jan. 12, 2026 (GLOBE NEWSWIRE) -- (NYSE: XPO) will hold its fourth quarter conference call and webcast on Thursday, February 5, at 8:30 a.m. Eastern Time. The company's results will be released earlier that morning and made available on . Access information:Call toll-free from US/Canada: 1-877-269-7756International callers: Live webcast online at: A replay of the conference call will be available until March 7, 2026, by calling toll-free (from US/Canada) 1-877-660-6853; interna...

 PRESS RELEASE

XPO Renews Partnership with TAT (Truckers Against Trafficking) for 202...

XPO Renews Partnership with TAT (Truckers Against Trafficking) for 2026 GREENWICH, Conn., Jan. 12, 2026 (GLOBE NEWSWIRE) -- (NYSE: XPO), a leading provider of freight transportation in North America, today announced that it has renewed its support for TAT (Truckers Against Trafficking), a nonprofit dedicated to educating and empowering the transportation industry to combat human trafficking. XPO will serve as a platinum partner of TAT for the sixth consecutive year. Mario Harik, chairman and chief executive officer of XPO, said, “At XPO, we’re proud to support efforts that make our comm...

 PRESS RELEASE

Novartis to add radioligand therapy manufacturing facility in Winter P...

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern USPurpose-built facility will strengthen Novartis RLT manufacturing network alongside existing Indiana, New Jersey, and recently completed California sitesNovartis RLT portfolio advancing with new isotopes, ligands and combination therapies, bringing innovation to new cancer types East Hanover, N.J., Ja...

 PRESS RELEASE

XPO Renews Support for Susan G. Komen® 3-Day Walks as Official Transpo...

XPO Renews Support for Susan G. Komen® 3-Day Walks as Official Transportation Partner GREENWICH, Conn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- (NYSE: XPO), a leading provider of freight transportation in North America, announced that it has renewed its long-standing commitment as the official transportation partner of the Susan G. Komen® 3-Day fundraising walks through March 2029.  “The 3-Day fundraising walks represent hope, strength and progress for those affected by breast cancer,” said Carolyn Roach, chief human resources officer of XPO. “Through our long-term partnership, we are proud t...

 PRESS RELEASE

XPO Announces Brad Jacobs to Step Down as Executive Chairman

XPO Announces Brad Jacobs to Step Down as Executive Chairman CEO Mario Harik to Become Chairman, while Continuing as CEO GREENWICH, Conn., Dec. 15, 2025 (GLOBE NEWSWIRE) -- (NYSE: XPO) announced today that Brad Jacobs will step down as Executive Chairman of the Board, effective December 31, 2025. Jacobs will transition to the role of Special Advisor to the Company through June 30, 2026. Mario Harik will serve as Chairman of the Board while continuing in his role as CEO, which he has held since 2022. Harik’s increased responsibility underscores the Company’s commitment to continuity of ...

Dominic Rose ... (+2)
  • Dominic Rose
  • Naresh Chouhan

Thematic - 2026 Outlook - "5 More Years" (55pgs)

For access to the full note, please contact Naresh Chouhan ( ) With EU Pharma (ex-Novo) now having reached decade high valuations vs EuroStoxx600, we believe the sector has broken out & the sustainability of the growth profile will now generate continued strong performance. Consensus 5yr sales & EPS CAGR’s stand at 4% & 7% for 15x 2026 PE. We show there is upside to this from underestimated pipelines where cons. rarely fully models “monster” drugs & from M&A which we expect to be strong at JPM ...

 PRESS RELEASE

Novartis breaks ground on flagship manufacturing hub in North Carolina

Novartis breaks ground on flagship manufacturing hub in North Carolina FDA Commissioner Marty Makary, North Carolina Governor Josh Stein and Novartis leadership highlight importance of new hub to US patients and local economyConstruction reflects company’s commitment to ensure end-to-end manufacturing of all key medicines for US patients in the US at scaleGroundbreaking marks continuation of Novartis investment and growth in the US, capping year of significant regulatory and manufacturing milestones East Hanover, December 12, 2025 – Novartis, a leading global innovative medicines company...

Pfizer Inc. - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

 PRESS RELEASE

XPO Provides North American LTL Operating Data for November 2025

XPO Provides North American LTL Operating Data for November 2025 GREENWICH, Conn., Dec. 01, 2025 (GLOBE NEWSWIRE) -- (NYSE: XPO), a leading provider of freight transportation in North America, today reported certain preliminary LTL segment operating metrics for November 2025. LTL tonnage per day decreased 5.4%, as compared with November 2024, attributable to a year-over-year decrease of 2.2% in shipments per day and a decrease of 3.2% in weight per shipment. Actual results for November 2025 may vary from the preliminary results reported above. About XPO XPO, Inc. (NYSE: XPO) is a leade...

XPO, Inc. - September 2025 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Martial Descoutures
  • Martial Descoutures
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch